# The Use of International GerdQ Questionnaire

> **NCT01489735** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 150 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01489735
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01489735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01489735, "The Use of International GerdQ Questionnaire". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01489735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*